Selective delivery of biologically active substances is designed to overcom
e nonspecific biodistribution of drugs and increase their local concentrati
on at the target tissue. Certain strategies are based on carrier-mediated d
elivery to selective tissues and organs through ligands recognized by recep
tors or other address molecules on target cells. Avidins offer an attractiv
e approach to organ- or tissue-selective targeting. Avidin and streptavidin
, two biotin-binding proteins, can be targeted to specific tissues when mod
ified with appropriate tissue markers. Their resistance to proteolytic enzy
mes supports long-term accumulation at the target tissue or organ, and thei
r biotin binding sites permit the delivery of biotinylated molecules or car
riers loaded with cytotoxic drugs or other bioactive substances. Modificati
on of the two proteins with tissue-specific markers (lactose for parenchyma
l and trinitrophenyl for nonparenchymal liver cells) resulted in high and p
rolonged accumulation in the target tissue. The modified proteins could tar
get high doses of chemotherapeutic drugs (CDDP and 5-fluorouridine) to the
liver through biotinyl dextran-derived carriers. Drug Dev. Res. 50:258-271,
2000. (C) 2000 Wiley-Liss, Inc.